Alcon recently received U.S. FDA approval for its AcrySof® IQ ReSTOR® +3.0D Multifocal Toric Intraocular Lens (IOL).
Designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery, the IOL is reportedly intended for use in adult patients who want good near, intermediate and distance vision with an increased potential for spectacle independence.
Alcon reportedly plans to commercialize AcrySof IQ ReSTOR +3.0D Multifocal Toric IOLs in the United States on a rolling basis starting in the first quarter of 2017. The product is already commercially available in the European Union, Australia, Canada, and many countries in Central and South America and Asia.
Click here to read the full press release.